The Enterprise Value as of December 2024 (TTM) for Pulmatrix, Inc. (PULM) is 10.26M

According to Pulmatrix, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 10.26M. This represents a change of -382.12% compared to the average of -3635101.37 of the last 4 quarters.

Pulmatrix, Inc. (PULM) Historical Enterprise Value (quarterly & annually)

How has PULM Enterprise Value performed in the past?

The mean historical Enterprise Value of Pulmatrix, Inc. over the last ten years is 4.07M. The current 10.26M Enterprise Value has changed 25.09% with respect to the historical average. Over the past ten years (40 quarters), PULM's Enterprise Value was at its highest in in the September 2015 quarter at 56.65M. The Enterprise Value was at its lowest in in the September 2022 quarter at -26984979.51.

Pulmatrix, Inc. (PULM) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Pulmatrix, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Pulmatrix, Inc. (PULM) Average Enterprise Value

How has PULM Enterprise Value performed in the past?

The current Enterprise Value of Pulmatrix, Inc. (PULM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Pulmatrix, Inc. (PULM) Enterprise Value vs. Peers

How is PULM’s Enterprise Value compared to its peers?

Pulmatrix, Inc.’s Enterprise Value is less than Capricor Therapeutics, Inc. (575.76M), less than Akari Therapeutics, Plc (10.29M), less than Diffusion Pharmaceuticals Inc. (10.50M), less than Soleno Therapeutics, Inc. (1.89B), less than Onconova Therapeutics, Inc. (0), less than Catalyst Biosciences, Inc. (32.62M), less than Bio-Path Holdings, Inc. (1.03B), greater than Moleculin Biotech, Inc. (4.24M), greater than Bellerophon Therapeutics, Inc. (-3378743.00), greater than Crinetics Pharmaceuticals, Inc. (-4235209.00), less than Assembly Biosciences, Inc. (4.74B), less than Neoleukin Therapeutics, Inc. (67.83M), greater than Instil Bio, Inc. (-6333315.00), less than CytomX Therapeutics, Inc. (220.42M), less than Achilles Therapeutics plc (55.32M), greater than null (-42104641.00),

Build a custom stock screener for Pulmatrix, Inc. (PULM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pulmatrix, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pulmatrix, Inc. (PULM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pulmatrix, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.